P-111 FREQUENCY OF LIVER STEATOSIS AND FIBROSIS DETERMINED BY FIBROSCAN AND CAP IN A SCREENING PROGRAM
| Autor: | Rossana Ráez León, Julio Santiago Marcelo, Sonia Salazar Ventura, María Grazia Venturelli Romero, Stefanie Salazar Rivas, Carlos Nureña Flores, Roxana Gallegos López, Claudia Mori Torres, Cecilia Cabrera Cabrejos, Flor Araujo León, Diego Rosales Ruiz, Rocío Ramos Miraval, Pedro Montes Teves, Jaime Fustamante Flores, Flor Beltran Valdivia, Carlos García-Encinas, Bertha Cárdenas Ramírez, Rocío Galloso Gentille, Vanessa Valenzuela Granados, Briny Omar Rodríguez Vargas |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
education.field_of_study Hepatology medicine.diagnostic_test business.industry Population Specialties of internal medicine General Medicine medicine.disease Gastroenterology Liver steatosis RC581-951 Fibrosis Internal medicine Epidemiology Nonalcoholic fatty liver disease medicine Elastography Steatosis Hepatic fibrosis education business |
| Zdroj: | Annals of Hepatology, Vol 24, Iss, Pp 100471-(2021) |
| ISSN: | 1665-2681 |
| Popis: | Introduction: Nonalcoholic fatty liver disease represents a worldwide public health problem, in Latin America a prevalence of around 30% is estimated, however in Peru we do not have large epidemiological studies about this. Objectives: To evaluate the frequency of liver steatosis determined by CAP (Controlled Attenuation Parameter) and liver fibrosis by hepatic elastography in a population of patients who participated in a screening campaign. Material and Methods: Descriptive and cross-sectional study. During the period September-December 2019, the ALEH Screening Fibroscan program was carried out in 4 reference hospitals in Lima and Callao. Patients were evaluated with a Fibroscan 530 device with M and XL probes. Those examinations that met the quality parameters were included for the study: 10 valid measurements, IQR |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|